300453 三鑫医疗
已收盘 10-23 15:00:00
资讯
新帖
简况
三鑫医疗(300453)披露取得股票回购专项贷款承诺函公告,10月22日股价下跌1.84%
证券之星 · 10-22 22:35
三鑫医疗(300453)披露取得股票回购专项贷款承诺函公告,10月22日股价下跌1.84%
股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》
证券之星 · 10-22
股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》
三鑫医疗(300453)披露股份回购方案公告,10月15日股价下跌1.54%
证券之星 · 10-15
三鑫医疗(300453)披露股份回购方案公告,10月15日股价下跌1.54%
三鑫医疗(300453.SZ)拟3000万元至6000万元回购股份
智通财经 · 10-15
三鑫医疗(300453.SZ)拟3000万元至6000万元回购股份
三鑫医疗(300453.SZ)发布前三季度业绩,归母净利润2.1亿元,同比增长13.68%
智通财经 · 10-15
三鑫医疗(300453.SZ)发布前三季度业绩,归母净利润2.1亿元,同比增长13.68%
三鑫医疗:第三季度净利润7816.83万元 同比增长11.89%
格隆汇 · 10-15
三鑫医疗:第三季度净利润7816.83万元 同比增长11.89%
股市必读:三鑫医疗新发布《关于全资子公司变更医疗器械生产许可证的公告》
证券之星 · 10-09
股市必读:三鑫医疗新发布《关于全资子公司变更医疗器械生产许可证的公告》
三鑫医疗(300453)披露相关债券2026年跟踪评级报告,9月28日股价上涨0.22%
证券之星 · 09-28
三鑫医疗(300453)披露相关债券2026年跟踪评级报告,9月28日股价上涨0.22%
“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?
红星资本局 · 09-22
“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?
股市必读:三鑫医疗新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
证券之星 · 09-14
股市必读:三鑫医疗新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
三鑫医疗(300453)披露首次回购公司股份公告,9月11日股价下跌0.22%
证券之星 · 09-11
三鑫医疗(300453)披露首次回购公司股份公告,9月11日股价下跌0.22%
股市必读:三鑫医疗新发布《第六届董事会第四次会议决议公告》
证券之星 · 09-11
股市必读:三鑫医疗新发布《第六届董事会第四次会议决议公告》
三鑫医疗(300453.SZ)拟2000万元至4000万元回购公司股份
智通财经 · 09-09
三鑫医疗(300453.SZ)拟2000万元至4000万元回购公司股份
三鑫医疗:拟以2000万元-4000万元回购公司股份
格隆汇 · 09-09
三鑫医疗:拟以2000万元-4000万元回购公司股份
研报掘金丨国盛证券:维持三鑫医疗“买入”评级,产能建设持续推进
格隆汇 · 09-09
研报掘金丨国盛证券:维持三鑫医疗“买入”评级,产能建设持续推进
三鑫医疗(300453)380.18万股限售股将于8月31日解禁,占总股本0.73%
证券之星 · 08-31
三鑫医疗(300453)380.18万股限售股将于8月31日解禁,占总股本0.73%
股市必读:三鑫医疗中报 - 第二季度单季净利润同比增长3.86%
证券之星 · 08-26
股市必读:三鑫医疗中报 - 第二季度单季净利润同比增长3.86%
图解三鑫医疗中报:第二季度单季净利润同比增长3.86%
证券之星 · 08-25
图解三鑫医疗中报:第二季度单季净利润同比增长3.86%
三鑫医疗(300453)披露2024年限制性股票激励计划第二个解除限售期解除限售条件成就的公告,8月24日股价下跌1.72%
证券之星 · 08-24
三鑫医疗(300453)披露2024年限制性股票激励计划第二个解除限售期解除限售条件成就的公告,8月24日股价下跌1.72%
三鑫医疗(300453)披露控股子公司以未分配利润转增注册资本公告,8月20日股价上涨3.44%
证券之星 · 08-20
三鑫医疗(300453)披露控股子公司以未分配利润转增注册资本公告,8月20日股价上涨3.44%
加载更多
公司概况
公司名称:
江西三鑫医疗科技股份有限公司
所属行业:
专用设备制造业
上市日期:
2015-05-15
主营业务:
江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液透析制水系统、一次性使用血液透析器、血液透析浓缩液、血液透析粉、一次性使用血液透析管路、一次性使用透析用留置针、透析液过滤器、一次性使用机用采血器、血液透析设备、血液透析滤过器、血液净化补液管路、连续性血液净化管路及附件。2025年,公司成功获批组建省级工业设计中心,荣获江西省先进级智能工厂、江西省数智工厂等荣誉,并入选省级培育工业互联网平台。数字化水平全面提升,智能化运营体系成效显著。
发行价格:
12.87
{"stockData":{"symbol":"300453","market":"SZ","secType":"STK","nameCN":"三鑫医疗","latestPrice":9.28,"timestamp":1792738983000,"preClose":9.09,"halted":0,"volume":8747790,"delay":0,"changeRate":0.0209,"floatShares":365000000,"shares":522000000,"eps":0.556,"marketStatus":"已收盘","change":0.19,"latestTime":"10-23 15:00:00","open":9.01,"high":9.29,"low":8.77,"amount":79006800,"amplitude":0.0572,"askPrice":9.28,"askSize":281,"bidPrice":9.27,"bidSize":359,"shortable":0,"etf":0,"ttmEps":0.556,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":5,"adr":0,"adjPreClose":9.09,"symbolType":"stock","openAndCloseTimeList":[[1792719000000,1792726200000],[1792731600000,1792738800000]],"highLimit":10,"lowLimit":8.18,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":522084275,"isCdr":false,"pbRate":3.14,"roa":"--","peRate":16.690647,"roe":"13.46%","epsLYR":0.5117,"committee":-0.505759,"marketValue":4845000000,"turnoverRate":0.024,"status":0,"floatMarketCap":3386000000},"requestUrl":"/m/hq/s/300453","defaultTab":"news","newsList":[{"id":"2677961068","title":"三鑫医疗(300453)披露取得股票回购专项贷款承诺函公告,10月22日股价下跌1.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677961068","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677961068?lang=zh_cn&edition=full","pubTime":"2026-10-22 22:35","pubTimestamp":1792679713,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘,三鑫医疗报收于9.09元,较前一交易日下跌1.84%,最新总市值为47.46亿元。该股当日开盘9.22元,最高9.32元,最低9.08元,成交额达5084.52万元,换手率为1.52%。近日,江西三鑫医疗科技股份有限公司披露《关于取得金融机构股票回购专项贷款承诺函的公告》。公司近日收到中信银行南昌分行出具的《贷款承诺函》,贷款金额不超过5,200万元,期限不超过3年,用途为股票回购专项贷款。最终贷款以正式合同为准,具体回购情况以实际执行为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200042912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677011716","title":"股市必读:三鑫医疗新发布《关于控股二级子公司获得漏血监测器医疗器械注册证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677011716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677011716?lang=zh_cn&edition=full","pubTime":"2026-10-22 03:32","pubTimestamp":1792611130,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘,三鑫医疗报收于9.26元,上涨0.0%,换手率1.33%,成交量4.86万手,成交额4531.66万元。当日关注点交易信息汇总:10月21日主力资金净流出88.71万元,占总成交额1.96%;游资资金净流出506.42万元,占总成交额11.17%。公司公告汇总:控股二级子公司江西钶维肽生物科技有限公司获颁漏血监测器《医疗器械注册证》,属江西省第二类创新医疗器械,有效期至2031年10月15日。该产品采用生物电流识别技术,已被认定为江西省第二类创新医疗器械。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200003324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1574","BK0251","BK1583","BK1100","300453","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675535185","title":"三鑫医疗(300453)披露股份回购方案公告,10月15日股价下跌1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675535185","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675535185?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:56","pubTimestamp":1792076172,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘,三鑫医疗报收于8.96元,较前一交易日下跌1.54%,最新总市值为46.78亿元。该股当日开盘9.03元,最高9.07元,最低8.91元,成交额达4094.67万元,换手率为1.25%。近日,江西三鑫医疗科技股份有限公司披露《关于股份回购方案的公告》。回购实施期限为自股东会审议通过之日起12个月内。本次回购不会导致公司控制权变更,亦不会影响公司上市地位。相关事项尚需提交股东会审议,存在未能获审议通过或回购无法实施等风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500040072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675258033","title":"三鑫医疗(300453.SZ)拟3000万元至6000万元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2675258033","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675258033?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:19","pubTimestamp":1792070381,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)发布公告,公司拟3000万元至6000万元回购股份,回购股份价格不超过13.86元/股,将用于注销并相应减少公司注册资本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507969.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675580834","title":"三鑫医疗(300453.SZ)发布前三季度业绩,归母净利润2.1亿元,同比增长13.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675580834","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675580834?lang=zh_cn&edition=full","pubTime":"2026-10-15 21:16","pubTimestamp":1792070191,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)披露2026年第三季度报告,前三季度公司实现营收13.05亿元,同比增长11.78%;归母净利润2.1亿元,同比增长13.68%;扣非净利润1.93亿元,同比增长15.59%;基本每股收益0.4037元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675586683","title":"三鑫医疗:第三季度净利润7816.83万元 同比增长11.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675586683","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675586683?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:50","pubTimestamp":1792061407,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674002334","title":"股市必读:三鑫医疗新发布《关于全资子公司变更医疗器械生产许可证的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674002334","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674002334?lang=zh_cn&edition=full","pubTime":"2026-10-09 02:32","pubTimestamp":1791484331,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘,三鑫医疗报收于9.05元,上涨0.0%,换手率1.17%,成交量4.28万手,成交额3883.49万元。公司公告汇总:全资子公司云南三鑫医疗科技有限公司完成《医疗器械生产许可证》变更,企业负责人由万小平变更为彭海波,许可期限为2026年9月30日至2031年9月29日。公司公告汇总:截至2026年9月30日,公司已回购股份2,489,700股,占总股本0.48%,支付资金22,527,777元,回购进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159883","BK1100","09996","BK1583","300453","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255694","title":"三鑫医疗(300453)披露相关债券2026年跟踪评级报告,9月28日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670255694?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:31","pubTimestamp":1790605879,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘,三鑫医疗报收于9.04元,较前一交易日上涨0.22%,最新总市值为47.2亿元。该股当日开盘9.02元,最高9.07元,最低8.86元,成交额达4164.47万元,换手率为1.27%。近日,江西三鑫医疗科技股份有限公司披露相关债券2026年跟踪评级报告。2026年上半年营业收入8.37亿元,净利润1.45亿元,总资产24.65亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669234144","title":"“药二代”密集走向台前,大多拥有海外名校背景,将如何接好“转型”这一棒?","url":"https://stock-news.laohu8.com/highlight/detail?id=2669234144","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669234144?lang=zh_cn&edition=full","pubTime":"2026-09-22 20:16","pubTimestamp":1790079360,"startTime":"0","endTime":"0","summary":"红星资本局注意到,“药二代”们正密集走向台前。与“创一代”不同的是,他们大多拥有海外名校背景,进入核心管理层的方式也各不相同。今年以来,还有多位“药二代”走向台前。多家药企处于业务转型期二代接棒或面临考验值得一提的是,近期迎来“药二代”上台的上市公司,多数处于业务转型期。“药二代”走向前台,企业如何完成转型,仍有待时间验证。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-09-22/doc-inistexc1956967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B031HY20.USD","LU1226288253.USD","BK0046","BK0077","300298","LU0501845795.SGD","LU1226287792.SGD","LU1813983027.USD","300453","01093","LU1226287529.USD","BK0114","LU1960683339.HKD","BK0102","BK0187","BK1191","600380","SG9999004220.SGD","LU1152091754.HKD","LU1226287875.USD","LU1328277881.USD","LU0067412154.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","IE0008368742.USD","688166","LU0314109678.HKD","LU1226288170.HKD","LU1993786604.SGD","LU0880133367.SGD","IE0008369823.USD","LU0140636845.USD","LU1951186391.HKD","LU0326950275.SGD","LU1152091168.USD","LU1807302812.USD","HK0000165453.HKD","BK0239","BK0028","LU1008478684.HKD","BK1521","BK0188","000513","LU0072913022.USD","KURE","LU2039709279.SGD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU0315179316.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663809","title":"股市必读:三鑫医疗新发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663809","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667663809?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:23","pubTimestamp":1789330990,"startTime":"0","endTime":"0","summary":"公司公告汇总:董事会审议通过回购议案后,披露截至9月9日的前十名股东及前十名无限售条件股东持股情况,彭义兴分别持股24.70%和8.84%。回购报告书江西三鑫医疗科技股份有限公司拟使用自有资金回购公司A股股份,用于转换公司发行的可转换为股票的公司债券。预计回购股份数量为137.36万股至274.73万股,占公司总股本的0.26%至0.53%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666523389","title":"三鑫医疗(300453)披露首次回购公司股份公告,9月11日股价下跌0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666523389","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666523389?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:39","pubTimestamp":1789119581,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,三鑫医疗报收于9.11元,较前一交易日下跌0.22%,最新总市值为47.56亿元。该股当日开盘9.13元,最高9.14元,最低9.0元,成交额达4720.19万元,换手率为1.42%。江西三鑫医疗科技股份有限公司于2026年9月10日首次通过回购专用证券账户以集中竞价交易方式回购股份550,000股,占公司总股本的0.11%。本次回购符合相关法律法规及公司回购方案的要求。公司后续将根据市场情况在六个月内继续实施回购计划,并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100038683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590233","title":"股市必读:三鑫医疗新发布《第六届董事会第四次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666590233?lang=zh_cn&edition=full","pubTime":"2026-09-11 02:09","pubTimestamp":1789063752,"startTime":"0","endTime":"0","summary":"公司公告汇总第六届董事会第四次会议决议公告江西三鑫医疗科技股份有限公司于2026年9月9日召开第六届董事会第四次会议,审议通过《关于回购公司股份方案的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666347533","title":"三鑫医疗(300453.SZ)拟2000万元至4000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666347533","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666347533?lang=zh_cn&edition=full","pubTime":"2026-09-09 20:26","pubTimestamp":1788956801,"startTime":"0","endTime":"0","summary":"智通财经APP讯,三鑫医疗(300453.SZ)发布公告,公司拟使用自有资金回购公司已发行的部分人民币普通股(A股)股票,并在未来用于转换公司发行的可转换为股票的公司债券。回购股份资金不低于2000万元且不超过4000万元。回购股份价格不超过14.56元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666807895","title":"三鑫医疗:拟以2000万元-4000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2666807895","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666807895?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:53","pubTimestamp":1788954813,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666302489","title":"研报掘金丨国盛证券:维持三鑫医疗“买入”评级,产能建设持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2666302489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666302489?lang=zh_cn&edition=full","pubTime":"2026-09-09 13:30","pubTimestamp":1788931814,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0052","BK0276","300453","002670","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663028166","title":"三鑫医疗(300453)380.18万股限售股将于8月31日解禁,占总股本0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663028166","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663028166?lang=zh_cn&edition=full","pubTime":"2026-08-31 08:02","pubTimestamp":1788134575,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,三鑫医疗于8月31日将有380.18万股限售股份解禁,为公司股权激励限售股份,占公司总股本0.73%。最近一年内,该股累计解禁384.96万股,占总股本的0.74%。本次解禁后,公司还有1.56亿股限售股份,占总股本29.91%。三鑫医疗主营业务:医疗器械研发、制造、销售和服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662655787","title":"股市必读:三鑫医疗中报 - 第二季度单季净利润同比增长3.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662655787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662655787?lang=zh_cn&edition=full","pubTime":"2026-08-26 08:42","pubTimestamp":1787704973,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘,三鑫医疗报收于9.7元,下跌0.21%,换手率3.09%,成交量11.18万手,成交额1.08亿元。股本股东变化股东户数变动截至2026年6月30日公司股东户数为1.86万户,较3月31日减少2944.0户,减幅为13.66%;户均持股数量由2.42万股增至2.81万股,户均持股市值为25.37万元。关于调整2024年限制性股票激励计划回购价格及回购注销部分限制性股票的公告因","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600014969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036732","title":"图解三鑫医疗中报:第二季度单季净利润同比增长3.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662036732?lang=zh_cn&edition=full","pubTime":"2026-08-25 02:14","pubTimestamp":1787595241,"startTime":"0","endTime":"0","summary":"证券之星消息,三鑫医疗2026年中报显示,上半年度公司主营收入8.37亿元,同比上升9.98%;归母净利润1.32亿元,同比上升14.77%;扣非净利润1.22亿元,同比上升17.8%;其中2026年第二季度,公司单季度主营收入4.28亿元,同比上升6.9%;单季度归母净利润6375.92万元,同比上升3.86%;单季度扣非净利润6036.9万元,同比上升14.5%;负债率36.43%,投资收益151.97万元,财务费用404.36万元,毛利率36.35%。财报数据概要请见下图:本文数据来源于三鑫医疗2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005251.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272867","title":"三鑫医疗(300453)披露2024年限制性股票激励计划第二个解除限售期解除限售条件成就的公告,8月24日股价下跌1.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661272867?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:19","pubTimestamp":1787581175,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,三鑫医疗报收于9.72元,较前一交易日下跌1.72%,最新总市值为50.75亿元。近日,江西三鑫医疗科技股份有限公司发布《关于2024年限制性股票激励计划第二个解除限售期解除限售条件成就的公告》。公告显示,公司2024年限制性股票激励计划第二个解除限售期解除限售条件已成就,符合解除限售条件的激励对象共110人,可解除限售的股份数量为380.1825万股,占公司总股本的0.7282%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400037198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660887332","title":"三鑫医疗(300453)披露控股子公司以未分配利润转增注册资本公告,8月20日股价上涨3.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660887332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660887332?lang=zh_cn&edition=full","pubTime":"2026-08-20 17:54","pubTimestamp":1787219674,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘,三鑫医疗报收于10.22元,较前一交易日上涨3.44%,最新总市值为53.36亿元。该股当日开盘9.98元,最高10.46元,最低9.98元,成交额达2.65亿元,换手率为7.2%。公司于近日披露《关于控股子公司以未分配利润转增注册资本暨完成工商变更登记的公告》。公告显示,江西三鑫医疗科技股份有限公司控股子公司成都威力生生物科技有限公司使用截至2026年6月30日的部分未分配利润800万元转增注册资本,注册资本由1,600万元增至2,400万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000032482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792900583506,"stockEarnings":[{"period":"1week","weight":0.0175},{"period":"1month","weight":0.022},{"period":"3month","weight":0.0221},{"period":"6month","weight":-0.0462},{"period":"1year","weight":0.0465},{"period":"ytd","weight":0.0993}],"compareEarnings":[{"period":"1week","weight":-0.0069},{"period":"1month","weight":-0.0625},{"period":"3month","weight":-0.0324},{"period":"6month","weight":-0.0954},{"period":"1year","weight":-0.0591},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西三鑫医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"19629人(较上一季度增加5.53%)","perCapita":"18585股","listingDate":"2015-05-15","address":"江西省南昌市南昌县小蓝经济开发区富山大道999号","registeredCapital":"52208万元","survey":" 江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液透析制水系统、一次性使用血液透析器、血液透析浓缩液、血液透析粉、一次性使用血液透析管路、一次性使用透析用留置针、透析液过滤器、一次性使用机用采血器、血液透析设备、血液透析滤过器、血液净化补液管路、连续性血液净化管路及附件。2025年,公司成功获批组建省级工业设计中心,荣获江西省先进级智能工厂、江西省数智工厂等荣誉,并入选省级培育工业互联网平台。数字化水平全面提升,智能化运营体系成效显著。","listedPrice":12.87},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三鑫医疗,300453,三鑫医疗股票,三鑫医疗股票老虎,三鑫医疗股票老虎国际,三鑫医疗行情,三鑫医疗股票行情,三鑫医疗股价,三鑫医疗股市,三鑫医疗股票价格,三鑫医疗股票交易,三鑫医疗股票购买,三鑫医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}